| Current Price | $67.51 | Mkt Cap | $152.6B |
|---|---|---|---|
| Open | $68.22 | P/E Ratio | 0.00 |
| Prev. Close | $0.00 | Div. (Yield) | $1.96 (2.9%) |
| Daily Range | $67.49 - $68.34 | Volume | 3,443,948 |
| 52-Wk Range | $56.75 - $68.53 | Avg. Daily Vol. | 9,171,421 |
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
| Current Price | $67.51 | Mkt Cap | $152.6B |
|---|---|---|---|
| Open | $68.22 | P/E Ratio | 0.00 |
| Prev. Close | $0.00 | Div. (Yield) | $1.96 (2.9%) |
| Daily Range | $67.49 - $68.34 | Volume | 3,443,948 |
| 52-Wk Range | $56.75 - $68.53 | Avg. Daily Vol. | 9,171,421 |
The best Bull and Bear pitches based on recency and number of recommendations.
recent upgrade. good pipeline.
Strong pipeline and a culture that wants to innovate. Strong focus on patients. Leadership seems to struggle with launching products and being competitive out the door. Long term will either find BMY on strong footing or acquired.
Read the most recent pitches from players about BMY.
Recs
FoolSpec
(< 20)
Submitted: 5/21/2021 10:36:39 PM :
Start Price:
$66.75
NYSE:BMY Score:
-3.87
Undervalued with a strong pipeline.
Recs
RES7
(82.60)
Submitted: 3/8/2021 1:24:15 PM :
Start Price:
$60.70
NYSE:BMY Score:
-1.93
Jonathon Webber SA
Recs
jjhegi
(68.83)
Submitted: 1/13/2021 11:28:51 AM :
Start Price:
$64.19
NYSE:BMY Score:
-10.33
Cheap stock in an expensive market. Berkshire just made a large purchase late last year.
Find the members with the highest scoring picks in BMY.
See what the Wall Street professionals think, according to their public statements and filings.
